Nanotechnology-enabled precision targeting of lung cancer stem cells: Recent developments and therapeutic implications.
An integrated framework linking LCSC niche regulation with nanotechnology-based precision therapeutics in lung cancer is established, and the therapeutic potential of multifunctional nanoplatforms is highlighted in modulating stemness-associated pathways, overcoming immune suppression, and disrupting metabolic adaptation.